Semaglutide has emerged as a novel treatment for insulin resistance. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to produce more insulin and curbing glucagon https://craigonxi408363.ourcodeblog.com/35908830/understanding-semaglutide-a-comprehensive-guide